(VIANEWS) – Hannon Armstrong Sustainable Infrastructure Capital (HASI), Cameco Corporation (CCJ), Ares Management L.P. (ARES) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Hannon Armstrong Sustainable Infrastructure Capital (HASI)
87.5% sales growth and 7.92% return on equity
Hannon Armstrong Sustainable Infrastructure Capital, Inc. provides capital and services to the energy efficiency, renewable energy, and other sustainable infrastructure markets in the United States. The company's projects include building or facility that reduce energy usage or cost through the use of solar generation and energy storage or energy efficiency improvements, including heating, ventilation, and air conditioning systems (HVAC), as well as lighting, energy controls, roofs, windows, building shells, and/or combined heat and power systems. It also focuses in the areas of grid connected projects that deploy cleaner energy sources, such as solar and wind to generate power; and other sustainable infrastructure projects, including upgraded transmission or distribution systems, water and storm water infrastructures, and other projects. The company qualifies as a real estate investment trust for U.S. federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 1981 and is headquartered in Annapolis, Maryland.
Earnings Per Share
As for profitability, Hannon Armstrong Sustainable Infrastructure Capital has a trailing twelve months EPS of $1.42.
PE Ratio
Hannon Armstrong Sustainable Infrastructure Capital has a trailing twelve months price to earnings ratio of 17.78. Meaning, the purchaser of the share is investing $17.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.92%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 7.5% and 9.4%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Hannon Armstrong Sustainable Infrastructure Capital’s EBITDA is 10.1.
Yearly Top and Bottom Value
Hannon Armstrong Sustainable Infrastructure Capital’s stock is valued at $25.25 at 01:22 EST, way below its 52-week high of $31.63 and way higher than its 52-week low of $13.22.
2. Cameco Corporation (CCJ)
46.6% sales growth and 6.05% return on equity
Cameco Corporation produces and sells uranium. It operates in two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles or reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.
Earnings Per Share
As for profitability, Cameco Corporation has a trailing twelve months EPS of $0.61.
PE Ratio
Cameco Corporation has a trailing twelve months price to earnings ratio of 68.25. Meaning, the purchaser of the share is investing $68.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.05%.
Volume
Today’s last reported volume for Cameco Corporation is 5995250 which is 10.37% above its average volume of 5431660.
Yearly Top and Bottom Value
Cameco Corporation’s stock is valued at $41.63 at 01:22 EST, way under its 52-week high of $51.33 and way higher than its 52-week low of $23.69.
Revenue Growth
Year-on-year quarterly revenue growth grew by 61.1%, now sitting on 2.59B for the twelve trailing months.
Moving Average
Cameco Corporation’s worth is below its 50-day moving average of $44.91 and above its 200-day moving average of $38.20.
3. Ares Management L.P. (ARES)
17.6% sales growth and 23.32% return on equity
Ares Management Corporation operates as an alternative asset manager in the United States, Europe, and Asia. The company's Tradable Credit Group segment manages various types of investment funds, such as commingled and separately managed accounts for institutional investors, and publicly traded vehicles and sub-advised funds for retail investors in the tradable and non-investment grade corporate credit markets. Its Direct Lending Group segment provides financing solutions to small-to-medium sized companies. The company's Private Equity Group segment focuses on majority or shared-control investments primarily in under-capitalized companies. Its Real Estate Group segment invests in new developments and the repositioning of assets, with a focus on control or majority-control investments; and originates and invests in a range of self-originated financing opportunities for middle-market owners and operators of commercial real estate. The firm was previously known as Ares Management, L.P. Ares Management Corporation was founded in 1997 and is headquartered in Los Angeles, California with additional offices in the United States, Europe and Asia. Ares Management GP LLC is the general partner of the company.
Earnings Per Share
As for profitability, Ares Management L.P. has a trailing twelve months EPS of $2.42.
PE Ratio
Ares Management L.P. has a trailing twelve months price to earnings ratio of 54.38. Meaning, the purchaser of the share is investing $54.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.32%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ares Management L.P.’s EBITDA is 70.36.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 32.4% and 16.7%, respectively.
4. Humana (HUM)
8.7% sales growth and 15.68% return on equity
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Earnings Per Share
As for profitability, Humana has a trailing twelve months EPS of $19.99.
PE Ratio
Humana has a trailing twelve months price to earnings ratio of 17.45. Meaning, the purchaser of the share is investing $17.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.68%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 34.3% and a negative 34%, respectively.
Yearly Top and Bottom Value
Humana’s stock is valued at $348.89 at 01:22 EST, way under its 52-week high of $541.21 and above its 52-week low of $334.54.
Volume
Today’s last reported volume for Humana is 772381 which is 61.94% below its average volume of 2029600.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.9%, now sitting on 106.37B for the twelve trailing months.
5. Sapiens International Corporation N.V. (SPNS)
7% sales growth and 14.74% return on equity
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Sapiens International Corporation N.V. has a trailing twelve months EPS of $1.12.
PE Ratio
Sapiens International Corporation N.V. has a trailing twelve months price to earnings ratio of 26.94. Meaning, the purchaser of the share is investing $26.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.74%.
Yearly Top and Bottom Value
Sapiens International Corporation N.V.’s stock is valued at $30.17 at 01:22 EST, under its 52-week high of $31.39 and way above its 52-week low of $18.86.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sapiens International Corporation N.V.’s EBITDA is 58.37.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 9.7% and 9.1%, respectively.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 15, 2023, the estimated forward annual dividend rate is 0.51 and the estimated forward annual dividend yield is 1.69%.
